NovaBay Pharmaceuticals, Inc. Logo

NovaBay Pharmaceuticals, Inc.

Develops and commercializes eyecare, skincare, and wound care products.

NBY | US

Overview

Corporate Details

ISIN(s):
US66987P2011
LEI:
Country:
United States of America
Address:
2000 POWELL STREET, SUITE 1150, 94608 EMERYVILLE

Description

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-28 01:15 English 5.1 KB
2025-11-25 23:26
FORM S-8
English 68.9 KB
2025-11-25 23:24
FORM S-3/A
English 292.3 KB
2025-11-07 22:01
FORM 10-Q
English 1.8 MB
2025-11-04 03:39
FORM 4
English 9.6 KB
2025-11-04 03:38
FORM 4
English 9.3 KB
2025-11-04 03:38
FORM 4
English 8.6 KB
2025-10-23 03:27
FORM 4A
English 12.5 KB
2025-10-23 03:22
FORM 3A
English 12.1 KB
2025-10-22 22:09
8-K
English 141.3 KB
2025-10-21 13:00
8-K
English 73.9 KB
2025-10-21 03:42 English 10.3 KB
2025-10-21 03:42 English 10.5 KB
2025-10-21 03:40
FORM 4
English 8.5 KB
2025-10-21 03:39
FORM 4
English 12.0 KB

Automate Your Workflow. Get a real-time feed of all NovaBay Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NovaBay Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NovaBay Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Develops stem cell therapeutics and regenerative medicine for incurable diseases.
South Korea
078160
Medivir Logo
A pharmaceutical company developing innovative drugs for cancer.
Sweden
MVIR
MediWound Ltd. Logo
Biopharmaceutical firm developing enzymatic therapeutics for non-surgical tissue repair.
United States of America
MDWD
Develops first-in-class therapies for oncology and autoimmune diseases.
South Korea
235980
Medrx Co.,Ltd. Logo
Develops pharmaceutical formulations using transdermal absorption technology.
Japan
4586
Medy-Tox Inc. Logo
Biopharmaceutical firm developing botulinum toxins, HA fillers, and dermocosmetics.
South Korea
086900
MeiraGTx Holdings plc Logo
A clinical-stage genetic medicine company treating eye, salivary, and CNS disorders.
United States of America
MGTX
Mendus Logo
Clinical-stage company developing immunotherapies to prevent tumor recurrence.
Sweden
IMMU
Merck & Co., Inc. Logo
A global biopharmaceutical company that develops medicines, vaccines, and animal health products.
United States of America
MRK
Mereo BioPharma Group plc Logo
Acquires and develops clinical-stage therapies for rare diseases.
United States of America
MREO

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.